Literature DB >> 24153126

High nasal burden of methicillin-resistant Staphylococcus aureus increases risk of invasive disease.

Rupak Datta1, Atia Shah, Susan S Huang, Eric Cui, Vinh Nguyen, Susan J Welbourne, Kathleen A Quan, Lauri Thrupp.   

Abstract

In a retrospective cohort study of 1,140 patients harboring methicillin-resistant Staphylococcus aureus, the nasal burden was low in 31%, category 1+ to 2+ in 54%, and category 3+ to 4+ in 15%. There was a significant trend in infection risk with increasing nasal burden (P = 0.007). In multivariate models, high nasal burden remained significantly associated with invasive infection.

Entities:  

Mesh：

Year:  2013        PMID： 24153126      PMCID： PMC3911445          DOI： 10.1128/JCM.01606-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  24 in total

1.  Nasal carriage of Staphylococcus aureus is a major risk factor for surgical-site infections in orthopedic surgery.

Authors:  M D Kalmeijer; E van Nieuwland-Bollen; D Bogaers-Hofman; G A de Baere
Journal:  Infect Control Hosp Epidemiol       Date:  2000-05       Impact factor: 3.254

Review 2.  Infections due to Staphylococcus aureus.

Authors:  D M Musher; S O McKenzie
Journal:  Medicine (Baltimore)       Date:  1977-09       Impact factor: 1.889

3.  Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group.

Authors:  C von Eiff; K Becker; K Machka; H Stammer; G Peters
Journal:  N Engl J Med       Date:  2001-01-04       Impact factor: 91.245

4.  Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers.

Authors:  Heiman F L Wertheim; Margreet C Vos; Alewijn Ott; Alex van Belkum; Andreas Voss; Jan A J W Kluytmans; Peter H J van Keulen; Christina M J E Vandenbroucke-Grauls; Marlene H M Meester; Henri A Verbrugh
Journal:  Lancet       Date:  2004 Aug 21-27       Impact factor: 79.321

5.  Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study.

Authors:  M D Kalmeijer; H Coertjens; P M van Nieuwland-Bollen; D Bogaers-Hofman; G A J de Baere; A Stuurman; A van Belkum; J A J W Kluytmans
Journal:  Clin Infect Dis       Date:  2002-07-15       Impact factor: 9.079

6.  Risk factors for nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus.

Authors:  M Pujol; C Peña; R Pallares; J Ayats; J Ariza; F Gudiol
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-01       Impact factor: 3.267

7.  Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection.

Authors:  Kepler A Davis; Justin J Stewart; Helen K Crouch; Christopher E Florez; Duane R Hospenthal
Journal:  Clin Infect Dis       Date:  2004-08-27       Impact factor: 9.079

8.  Colonization and infection with methicillin-resistant Staphylococcus aureus: associated factors and eradication.

Authors:  A Asensio; A Guerrero; C Quereda; M Lizán; M Martinez-Ferrer
Journal:  Infect Control Hosp Epidemiol       Date:  1996-01       Impact factor: 3.254

9.  Staphylococcus aureus bacteremia. Current clinical patterns.

Authors:  C M Nolan; H N Beaty
Journal:  Am J Med       Date:  1976-04       Impact factor: 4.965

10.  The association between Staphylococcus aureus bacteremia and bacteriuria.

Authors:  B K Lee; K Crossley; D N Gerding
Journal:  Am J Med       Date:  1978-08       Impact factor: 4.965
View more
  14 in total

1.  Significance of Staphylococcus epidermidis in Health Care-Associated Infections, from Contaminant to Clinically Relevant Pathogen: This Is a Wake-Up Call!

Authors:  Micael Widerström
Journal:  J Clin Microbiol       Date:  2016-05-11       Impact factor: 5.948

2.  Colonization of epidermal tissue by Staphylococcus aureus produces localized hypoxia and stimulates secretion of antioxidant and caspase-14 proteins.

Authors:  Abdul G Lone; Erhan Atci; Ryan Renslow; Haluk Beyenal; Susan Noh; Boel Fransson; Nehal Abu-Lail; Jeong-Jin Park; David R Gang; Douglas R Call
Journal:  Infect Immun       Date:  2015-05-18       Impact factor: 3.441

3.  Modelling methicillin-resistant Staphylococcus aureus decolonization: interactions between body sites and the impact of site-specific clearance.

Authors:  Onur Poyraz; Mohamad R A Sater; Loren G Miller; James A McKinnell; Susan S Huang; Yonatan H Grad; Pekka Marttinen
Journal:  J R Soc Interface       Date:  2022-06-15       Impact factor: 4.293

4.  Comparative evaluation of MRSA nasal colonization epidemiology in the urban and rural secondary school community of Kurdistan, Iraq.

Authors:  Nawfal R Hussein; Zarrin Basharat; Ary H Muhammed; Samim A Al-Dabbagh
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

5.  Staphylococcus aureus Infections After Elective Cardiothoracic Surgery: Observations From an International Randomized Placebo-Controlled Trial of an Investigational S aureus Vaccine.

Authors:  Keith B Allen; Vance G Fowler; James S Gammie; Jonathan S Hartzel; Matthew T Onorato; Mark J DiNubile; Ajoke Sobanjo-Ter Meulen
Journal:  Open Forum Infect Dis       Date:  2014-08-26       Impact factor: 3.835

6.  Nasal screening for MRSA: different swabs--different results!

Authors:  Philipp Warnke; Hagen Frickmann; Peter Ottl; Andreas Podbielski
Journal:  PLoS One       Date:  2014-10-29       Impact factor: 3.240

7.  Nasal screening for Staphylococcus aureus--daily routine with improvement potentials.

Authors:  Philipp Warnke; Tim Harnack; Peter Ottl; Guenther Kundt; Andreas Podbielski
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240

Review 8.  Applying Convergent Immunity to Innovative Vaccines Targeting Staphylococcus aureus.

Authors:  Michael R Yeaman; Scott G Filler; Clint S Schmidt; Ashraf S Ibrahim; John E Edwards; John P Hennessey
Journal:  Front Immunol       Date:  2014-09-26       Impact factor: 7.561

9.  Some are more equal--a comparative study on swab uptake and release of bacterial suspensions.

Authors:  Philipp Warnke; Liesa Warning; Andreas Podbielski
Journal:  PLoS One       Date:  2014-07-10       Impact factor: 3.240

10.  Utilizing Moist or Dry Swabs for the Sampling of Nasal MRSA Carriers? An In Vivo and In Vitro Study.

Authors:  Philipp Warnke; Annette Devide; Mirjam Weise; Hagen Frickmann; Norbert Georg Schwarz; Holger Schäffler; Peter Ottl; Andreas Podbielski
Journal:  PLoS One       Date:  2016-09-14       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.